🔎 Trials Near Me

Akèy › Sistèm Imunitè ak Twoub › Washington › Seattle

Etid klinik pou Sistèm Imunitè ak Twoub nan Seattle, WA

6 etid pou Sistèm Imunitè ak Twoub ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • University of Washingto, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Ap rekriteEtid obsèvasyon
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Tout laj · Tout sèks · Mizajou Sep 17, 2026 · NCT04242095

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

Ap rekriteFaz 2
  • University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Laj 18 a 69 · Tout sèks · Mizajou Sep 15, 2026 · NCT07699380

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • University of Washingto, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Ap rekriteFaz 1/2
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Ap rekriteFaz 1/2
  • University of Washington Medical Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078

Etid Sistèm Imunitè ak Twoub nan lòt vil

Lòt etid nan Seattle

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.